These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34831074)

  • 1. The Retinoblastoma Tumor Suppressor Is Required for the NUP98-HOXA9-Induced Aberrant Nuclear Envelope Phenotype.
    Vaz M; Fahrenkrog B
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype.
    Fahrenkrog B; Martinelli V; Nilles N; Fruhmann G; Chatel G; Juge S; Sauder U; Di Giacomo D; Mecucci C; Schwaller J
    PLoS One; 2016; 11(3):e0152321. PubMed ID: 27031510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis.
    Xu H; Valerio DG; Eisold ME; Sinha A; Koche RP; Hu W; Chen CW; Chu SH; Brien GL; Park CY; Hsieh JJ; Ernst P; Armstrong SA
    Cancer Cell; 2016 Dec; 30(6):863-878. PubMed ID: 27889185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein.
    Markiewicz E; Dechat T; Foisner R; Quinlan RA; Hutchison CJ
    Mol Biol Cell; 2002 Dec; 13(12):4401-13. PubMed ID: 12475961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.
    Mendes A; Jühlen R; Bousbata S; Fahrenkrog B
    Cells; 2020 Jul; 9(7):. PubMed ID: 32664447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.
    Takeda A; Sarma NJ; Abdul-Nabi AM; Yaseen NR
    J Biol Chem; 2010 May; 285(21):16248-57. PubMed ID: 20233715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
    Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
    Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes.
    Oka M; Mura S; Yamada K; Sangel P; Hirata S; Maehara K; Kawakami K; Tachibana T; Ohkawa Y; Kimura H; Yoneda Y
    Elife; 2016 Jan; 5():e09540. PubMed ID: 26740045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
    Wang GG; Cai L; Pasillas MP; Kamps MP
    Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins.
    Sarma NJ; Yaseen NR
    PLoS One; 2013; 8(6):e67032. PubMed ID: 23840580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.
    Sarma NJ; Yaseen NR
    J Biol Chem; 2011 Nov; 286(45):38989-9001. PubMed ID: 21937451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation.
    Chandra B; Michmerhuizen NL; Shirnekhi HK; Tripathi S; Pioso BJ; Baggett DW; Mitrea DM; Iacobucci I; White MR; Chen J; Park CG; Wu H; Pounds S; Medyukhina A; Khairy K; Gao Q; Qu C; Abdelhamed S; Gorman SD; Bawa S; Maslanka C; Kinger S; Dogra P; Ferrolino MC; Di Giacomo D; Mecucci C; Klco JM; Mullighan CG; Kriwacki RW
    Cancer Discov; 2022 Apr; 12(4):1152-1169. PubMed ID: 34903620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nup98-homeodomain fusions interact with endogenous Nup98 during interphase and localize to kinetochores and chromosome arms during mitosis.
    Xu S; Powers MA
    Mol Biol Cell; 2010 May; 21(9):1585-96. PubMed ID: 20237156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger.
    Wang GG; Song J; Wang Z; Dormann HL; Casadio F; Li H; Luo JL; Patel DJ; Allis CD
    Nature; 2009 Jun; 459(7248):847-51. PubMed ID: 19430464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis.
    Funasaka T; Nakano H; Wu Y; Hashizume C; Gu L; Nakamura T; Wang W; Zhou P; Moore MA; Sato H; Wong RW
    Cell Cycle; 2011 May; 10(9):1456-67. PubMed ID: 21467841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic therapy restores normal hematopoiesis in a zebrafish model of NUP98-HOXA9-induced myeloid disease.
    Deveau AP; Forrester AM; Coombs AJ; Wagner GS; Grabher C; Chute IC; Léger D; Mingay M; Alexe G; Rajan V; Liwski R; Hirst M; Steigmaier K; Lewis SM; Look AT; Berman JN
    Leukemia; 2015 Oct; 29(10):2086-97. PubMed ID: 26017032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.
    Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLL is essential for NUP98-HOXA9-induced leukemia.
    Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
    Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells.
    Ghannam G; Takeda A; Camarata T; Moore MA; Viale A; Yaseen NR
    J Biol Chem; 2004 Jan; 279(2):866-75. PubMed ID: 14561764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion.
    Zhang Y; Guo Y; Gough SM; Zhang J; Vann KR; Li K; Cai L; Shi X; Aplan PD; Wang GG; Kutateladze TG
    Nat Commun; 2020 Jul; 11(1):3339. PubMed ID: 32620764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.